Detalhe da pesquisa
1.
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer.
Mol Cancer Ther
; 23(6): 823-835, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442920